Skip to main content Back to Top


Dextran Low Molecular Weight (Dextran 40), 10% Injection

Reason for the Shortage

    • Hospira states the reason for the shortage was manufacturing delay and increased demand.

Available Products

    • Dextran 40, Pfizer, 10% in 500 mL 0.9% Sodium Chloride, 12 count, NDC 00409-7419-03
    • Dextran 40, Pfizer, 10% in 500 mL 5% Dextrose, 12 count, NDC 00409-7418-03

Estimated Resupply Dates

    • Hospira has both Dextran 40 presentations available.


Updated May 17, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 27, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins